Article Versions Notes

Leone GM, Candido S, Lavoro A, Vivarelli S, Gattuso G, Calina D, Libra M, Falzone L. Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics. 2023; 15(4):1252. https://doi.org/10.3390/pharmaceutics15041252

Leone, Gian Marco, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, and Luca Falzone. 2023. "Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer" Pharmaceutics 15, no. 4: 1252. https://doi.org/10.3390/pharmaceutics15041252

Leone, G. M., Candido, S., Lavoro, A., Vivarelli, S., Gattuso, G., Calina, D., Libra, M., & Falzone, L. (2023). Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics, 15(4), 1252. https://doi.org/10.3390/pharmaceutics15041252